239 related articles for article (PubMed ID: 20425247)
1. The spectrum of atherosclerotic coronary artery disease in HIV patients.
Hakeem A; Bhatti S; Cilingiroglu M
Curr Atheroscler Rep; 2010 Mar; 12(2):119-24. PubMed ID: 20425247
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
3. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
4. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
[TBL] [Abstract][Full Text] [Related]
5. Coronary Artery Disease in Patients with HIV Infection: An Update.
Patel AA; Budoff MJ
Am J Cardiovasc Drugs; 2021 Jul; 21(4):411-417. PubMed ID: 33184766
[TBL] [Abstract][Full Text] [Related]
6. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
[TBL] [Abstract][Full Text] [Related]
7. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery disease in patients with HIV infection.
Patel AA; Budoff MJ
Am J Cardiovasc Drugs; 2015 Apr; 15(2):81-7. PubMed ID: 25672641
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery disease in patients with human immunodeficiency virus infection.
Mondal P; Aljizeeri A; Small G; Malhotra S; Harikrishnan P; Affandi JS; Buechel RR; Dwivedi G; Al-Mallah MH; Jain D
J Nucl Cardiol; 2021 Apr; 28(2):510-530. PubMed ID: 32820424
[TBL] [Abstract][Full Text] [Related]
10. HIV and coronary heart disease: time for a better understanding.
Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'.
Acevedo M; Sprecher DL; Calabrese L; Pearce GL; Coyner DL; Halliburton SS; White RD; Sykora E; Kondos GT; Hoff JA
Atherosclerosis; 2002 Aug; 163(2):349-54. PubMed ID: 12052482
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of HIV-related coronary artery disease.
Miller LH; Coppola JT
Curr HIV/AIDS Rep; 2011 Jun; 8(2):114-21. PubMed ID: 21344188
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
15. Acute coronary syndromes in patients with HIV.
Seecheran VK; Giddings SL; Seecheran NA
Coron Artery Dis; 2017 Mar; 28(2):166-172. PubMed ID: 27845996
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery disease and HIV; getting to the HAART of the matter.
Mavroudis CA; Majumder B; Loizides S; Christophides T; Johnson M; Rakhit RD
Int J Cardiol; 2013 Aug; 167(4):1147-53. PubMed ID: 23041017
[TBL] [Abstract][Full Text] [Related]
17. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.
Lang S; Boccara F; Mary-Krause M; Cohen A
Arch Cardiovasc Dis; 2015 Mar; 108(3):206-15. PubMed ID: 25725995
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
